Literature DB >> 31346680

[Treatment of pain in people with dementia].

Matthias Schuler1.   

Abstract

The causes of pain must always be clarified, as long as it can be justified. In dementia the placebo effect can be lacking. A treatment on demand is difficult to implement. Correctly applied nonmedicinal treatment has few unwanted effects but mostly needs constant support by personnel. Medications with anticholinergic effects should be used with caution due to the high risk of delirium and falling. With analgesics and coanalgesics the principles of geriatric treatment must also be adhered to: start low, go slow. Complaints that can be triggered by analgesics or coanalgesics should be recorded before starting treatment. Education and clarification by therapists are given priority. Multimorbidity and polypharmacy restrict the analgesic treatment. Strategies of self-efficacy and other psychological procedures have limited implementation. The course of treatment is difficult to monitor.

Entities:  

Keywords:  Acute pain; Chronic pain; Intervention; Multimorbidity; Patient monitoring

Mesh:

Substances:

Year:  2019        PMID: 31346680     DOI: 10.1007/s00391-019-01578-4

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  30 in total

1.  Effects on pain of a stepwise multidisciplinary intervention (STA OP!) that targets pain and behavior in advanced dementia: A cluster randomized controlled trial.

Authors:  Marjoleine J C Pieper; Jenny T van der Steen; Anneke L Francke; Erik J A Scherder; Jos W R Twisk; Wilco P Achterberg
Journal:  Palliat Med       Date:  2017-02-01       Impact factor: 4.762

2.  Long-term opioid use in non-cancer pain.

Authors:  Winfried Häuser; Fritjof Bock; Peter Engeser; Thomas Tölle; Anne Willweber-Strumpfe; Frank Petzke
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

3.  Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.

Authors:  John T Chibnall; Raymond C Tait; Bonnie Harman; Rebecca A Luebbert
Journal:  J Am Geriatr Soc       Date:  2005-11       Impact factor: 5.562

4.  [Assessment of pain in advanced dementia. Construct validity of the German PAINAD].

Authors:  H D Basler; D Hüger; R Kunz; J Luckmann; A Lukas; T Nikolaus; M S Schuler
Journal:  Schmerz       Date:  2006-11       Impact factor: 1.107

5.  Relationship between pain and opioid analgesics on the development of delirium following hip fracture.

Authors:  R Sean Morrison; Jay Magaziner; Marvin Gilbert; Kenneth J Koval; Mary Ann McLaughlin; Gretchen Orosz; Elton Strauss; Albert L Siu
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-01       Impact factor: 6.053

6.  [Treatment of elderly with chronic pain in geriatric care and pain therapy facilities in Germany. Survey results].

Authors:  M Schuler; A Becker; G Lindena; P Mattenklodt
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

7.  Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.

Authors:  Robert H Dworkin; Dennis C Turk; Kathleen W Wyrwich; Dorcas Beaton; Charles S Cleeland; John T Farrar; Jennifer A Haythornthwaite; Mark P Jensen; Robert D Kerns; Deborah N Ader; Nancy Brandenburg; Laurie B Burke; David Cella; Julie Chandler; Penny Cowan; Rozalina Dimitrova; Raymond Dionne; Sharon Hertz; Alejandro R Jadad; Nathaniel P Katz; Henrik Kehlet; Lynn D Kramer; Donald C Manning; Cynthia McCormick; Michael P McDermott; Henry J McQuay; Sanjay Patel; Linda Porter; Steve Quessy; Bob A Rappaport; Christine Rauschkolb; Dennis A Revicki; Margaret Rothman; Kenneth E Schmader; Brett R Stacey; Joseph W Stauffer; Thorsten von Stein; Richard E White; James Witter; Stojan Zavisic
Journal:  J Pain       Date:  2007-12-11       Impact factor: 5.820

8.  Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial.

Authors:  Bettina S Husebo; Clive Ballard; Reidun Sandvik; Odd Bjarte Nilsen; Dag Aarsland
Journal:  BMJ       Date:  2011-07-15

Review 9.  Metamizole-associated adverse events: a systematic review and meta-analysis.

Authors:  Thomas Kötter; Bruno R da Costa; Margrit Fässler; Eva Blozik; Klaus Linde; Peter Jüni; Stephan Reichenbach; Martin Scherer
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 10.  Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review.

Authors:  Mohammed Saji Salahudeen; Stephen B Duffull; Prasad S Nishtala
Journal:  BMC Geriatr       Date:  2015-03-25       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.